Zdrowie i gospodarka · 26/09/2003

Effective Strategies to Assist in Product Development: Counter Terrorism Products Regulated by the FDA's CBER

The U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) will host a public workshop to discuss effective strategies for developing counter-terrorism products. The workshop aims to assist in product development and regulation of these products.